EA201001592A1 - Гомеопатическое лекарственное средство - Google Patents
Гомеопатическое лекарственное средствоInfo
- Publication number
- EA201001592A1 EA201001592A1 EA201001592A EA201001592A EA201001592A1 EA 201001592 A1 EA201001592 A1 EA 201001592A1 EA 201001592 A EA201001592 A EA 201001592A EA 201001592 A EA201001592 A EA 201001592A EA 201001592 A1 EA201001592 A1 EA 201001592A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- homeopathic
- neurological diseases
- medicinal
- treatment
- treating
- Prior art date
Links
- 230000001632 homeopathic effect Effects 0.000 title abstract 6
- 208000012902 Nervous system disease Diseases 0.000 abstract 3
- 208000025966 Neurological disease Diseases 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 2
- 239000004615 ingredient Substances 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- 239000002775 capsule Substances 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- -1 elixirs Substances 0.000 abstract 1
- 239000000839 emulsion Substances 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 239000007937 lozenge Substances 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 231100000957 no side effect Toxicity 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 239000006187 pill Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 239000006188 syrup Substances 0.000 abstract 1
- 235000020357 syrup Nutrition 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Alternative & Traditional Medicine (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Изобретение относится к медицине, в частности к гомеопатическому лекарственному средству для лечения неврологических заболеваний, а также к способу его приготовления. Гомеопатическое средство совместно с физиологически приемлемыми носителями содержит тинктуры и/или смесь гомеопатических препаратов, при этом пропорция каждого ингредиента из одной группы варьируется от 1:1 до 1:10 по отношению к элементу другой группы. Лекарственная форма средства может быть в одной из таких форм, как таблетки, капсулы, порошки, крупинки, леденцы, пилюли, гранулы, растворы, сиропы, эликсиры, суспензии, эмульсии. Данное гомеопатическое средство эффективно при лечении некоторых типов неврологических заболеваний, оно стабильно, не токсично, побочные эффекты при лечении отсутствуют, его просто и легко приготовить, оно может сочетаться с любыми другими гомеопатическими препаратами для достижения желаемого эффекта, оно является общедоступным лекарственным средством для лечения ряда неврологических заболеваний, при этом не требуется практикующаяся в классической гомеопатии лекарственная индивидуализация с назначением единственного лекарственного ингредиента на одну дозу приёма.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN940MU2008 | 2008-04-29 | ||
PCT/IN2009/000253 WO2009133573A2 (en) | 2008-04-29 | 2009-04-27 | A homeopathic formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201001592A1 true EA201001592A1 (ru) | 2011-08-30 |
Family
ID=54253313
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201001592A EA201001592A1 (ru) | 2008-04-29 | 2009-04-27 | Гомеопатическое лекарственное средство |
Country Status (15)
Country | Link |
---|---|
US (1) | US20110038949A1 (ru) |
EP (1) | EP2296681A4 (ru) |
JP (2) | JP2011518876A (ru) |
KR (1) | KR101321031B1 (ru) |
CN (1) | CN102014939A (ru) |
AU (1) | AU2009241221B2 (ru) |
BR (1) | BRPI0912026A2 (ru) |
CA (1) | CA2722121A1 (ru) |
CH (1) | CH701268B1 (ru) |
EA (1) | EA201001592A1 (ru) |
IL (1) | IL208902A (ru) |
MX (1) | MX339704B (ru) |
MY (1) | MY161415A (ru) |
SG (1) | SG190594A1 (ru) |
WO (1) | WO2009133573A2 (ru) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0917684A2 (pt) * | 2008-08-29 | 2015-12-01 | Nancy Josephine Polich | método terapêutico homeopático |
WO2011085307A1 (en) * | 2010-01-11 | 2011-07-14 | Phoenix Biotechnology, Inc. | Method of treating neurological conditions with cardiac glycosides |
EP2568958A1 (en) * | 2010-05-14 | 2013-03-20 | Deseret Biologicals, Inc. | Formulations of diluted genetic material and methods for making same |
FR2962909A1 (fr) * | 2010-07-21 | 2012-01-27 | Oleg Iliich Epshtein | Composition pharmaceutique d'association et son utilisation dans des procedes pour traiter les maladies ou affections associees avec une maladie ou affection respiratoire |
US10022335B2 (en) | 2011-03-03 | 2018-07-17 | Nancy Josephine Polich | Homeopathic therapeutic method and compositions |
US9603898B2 (en) | 2011-03-23 | 2017-03-28 | Deseret Biologicals, Inc. | Formulations of diluted amino acid segments and methods for making same |
CN114306171A (zh) * | 2011-03-28 | 2022-04-12 | 玫琳凯有限公司 | 局部皮肤用组合物及其用途 |
US9545429B1 (en) * | 2011-09-03 | 2017-01-17 | Biolyte Laboratories, Llc | Homeopathic formulations |
EP2591823A1 (en) * | 2011-11-11 | 2013-05-15 | Biologische Heilmittel Heel GmbH | Composition for treating or preventing neurodegenerative disorders |
RU2484839C1 (ru) * | 2012-02-06 | 2013-06-20 | Михаил Михайлович Шашурин | Способ получения экстракта рододендрона золотистого с пониженным содержанием стероидных (сердечных) гликозидов |
WO2013138306A1 (en) | 2012-03-15 | 2013-09-19 | Princeton Biotechnology Corporation | Compositions and methods for treatment of pain |
US8551535B1 (en) | 2012-08-06 | 2013-10-08 | Sarah McCann | Homeopathic remedies and methods for enhancing weight loss |
US9265458B2 (en) | 2012-12-04 | 2016-02-23 | Sync-Think, Inc. | Application of smooth pursuit cognitive testing paradigms to clinical drug development |
US9380976B2 (en) | 2013-03-11 | 2016-07-05 | Sync-Think, Inc. | Optical neuroinformatics |
WO2015030567A1 (es) * | 2013-08-30 | 2015-03-05 | Zamarripa Blas Juan Alberto | Mejoras a formulación auxiliar para contrarrestar efectos adversos de tratamientos contra el cáncer y de tratamientos contra algunas enfermedades víricas |
KR101540107B1 (ko) * | 2015-02-05 | 2015-07-30 | 주식회사 다림바이오텍 | 반복적 희석 및 진탕을 이용한 경구용 제제의 제조방법 |
US20170290873A1 (en) * | 2016-04-08 | 2017-10-12 | Stellalife | Method Of Using Homeopathic Kit Containing Gel, Rinse And Spray For Management Of Post-Oral Surgical Recovery And Maintenance Of Oral Health |
US10499584B2 (en) | 2016-05-27 | 2019-12-10 | New West Genetics | Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles |
US10828251B1 (en) | 2017-01-14 | 2020-11-10 | Biolyte Laboratories, Llc | Homeopathic formulations |
US10617634B1 (en) | 2017-03-10 | 2020-04-14 | Biolyte Laboratories, Llc | Topical homeopathic formulations for menstrual cramps |
WO2019104442A1 (en) * | 2017-11-30 | 2019-06-06 | Canopy Growth Corporation | Liquid dosage forms, methods of making and use |
WO2020072850A1 (en) * | 2018-10-04 | 2020-04-09 | Stellalife, Inc. | Compositions and methods for promoting and maintaining oral health |
EP4069215A4 (en) | 2019-12-06 | 2024-01-17 | Jlabs Beauty LLC | TOPICAL COMPOSITIONS CONTAINING ROSE OIL AND CANNABIDIOL AND METHODS OF PREPARING AND USING THE SAME |
KR102273322B1 (ko) * | 2020-04-29 | 2021-07-06 | 우보한의연구소(주) | 복합 한약재 추출물을 유효성분으로 포함하는 알츠하이머병 예방, 치료, 또는 개선용 조성물 |
RU2746080C1 (ru) * | 2020-07-20 | 2021-04-06 | Сергей Анатольевич Небера | Гомеопатическое средство для купирования тика век |
EP4368172A1 (de) * | 2022-11-11 | 2024-05-15 | Gernot A. Overbeck | Verfahren zur herstellung eines analogen homöopathischen wirkstoffs, vorrichtung zur durchführung des verfahrens und computerprogrammprodukt |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2073515C1 (ru) * | 1993-01-20 | 1997-02-20 | Игорь Электринович Острейковский | Способ лечения травматического поражения головного мозга |
RU2074714C1 (ru) * | 1993-03-11 | 1997-03-10 | Игорь Электринович Острейковский | Способ лечения пациентов с поражением центральной нервной системы |
US20060088575A1 (en) * | 1994-03-31 | 2006-04-27 | Brewitt Barbara A | Homeopathic preparations of purified growth factors and purified growth hormones and associated carriers |
DE19738903A1 (de) * | 1997-09-05 | 1999-03-11 | Reimar Dr Med Banis | Stoffe |
RU2143275C1 (ru) * | 1999-05-06 | 1999-12-27 | Общество с ограниченной ответственностью "Доктор Н" | Гомеопатическое лекарственное средство для лечения бессонницы и повышенной нервной возбудимости "валериана-плюс мультигран" |
RU2150288C1 (ru) * | 1999-10-25 | 2000-06-10 | Небера Сергей Анатольевич | Гомеопатическое средство для лечения спазма аккомодации |
RU2224526C1 (ru) * | 2002-11-04 | 2004-02-27 | Государственное учреждение Научно-исследовательский институт психического здоровья Томского научного центра СО РАМН | Средство для профилактики и лечения боевой психической травмы |
CA2518965C (en) * | 2003-03-14 | 2018-10-30 | Nutrition Research Inc. | Homeopathic formulations useful for treating pain and/or inflammmation |
US7037532B2 (en) * | 2004-03-03 | 2006-05-02 | Innovation Ventures, Llc | Hangover relief composition |
US20050249763A1 (en) * | 2004-04-19 | 2005-11-10 | L'oreal | Kit for formulating a cosmetic product |
US20060165812A1 (en) * | 2005-01-21 | 2006-07-27 | Amershire Investment Corporation | Method and topical formulation for treating headaches |
US20070275096A1 (en) * | 2006-05-19 | 2007-11-29 | Trp, Inc., A Nevada Corporation | Composition and methodology for the treatment of hearing impairment symptoms |
WO2009047004A1 (en) * | 2007-10-10 | 2009-04-16 | Daniel Farrington | A homeopathic complex |
-
2009
- 2009-04-27 MY MYPI2010005054A patent/MY161415A/en unknown
- 2009-04-27 AU AU2009241221A patent/AU2009241221B2/en not_active Ceased
- 2009-04-27 US US12/989,113 patent/US20110038949A1/en not_active Abandoned
- 2009-04-27 CA CA2722121A patent/CA2722121A1/en not_active Abandoned
- 2009-04-27 WO PCT/IN2009/000253 patent/WO2009133573A2/en active Application Filing
- 2009-04-27 CN CN2009801154875A patent/CN102014939A/zh active Pending
- 2009-04-27 CH CH01796/10A patent/CH701268B1/de unknown
- 2009-04-27 EA EA201001592A patent/EA201001592A1/ru unknown
- 2009-04-27 KR KR1020107026630A patent/KR101321031B1/ko active IP Right Grant
- 2009-04-27 MX MX2010011715A patent/MX339704B/es active IP Right Grant
- 2009-04-27 JP JP2011506833A patent/JP2011518876A/ja active Pending
- 2009-04-27 SG SG2013032313A patent/SG190594A1/en unknown
- 2009-04-27 BR BRPI0912026A patent/BRPI0912026A2/pt not_active Application Discontinuation
- 2009-04-27 EP EP09738579A patent/EP2296681A4/en not_active Withdrawn
-
2010
- 2010-10-24 IL IL208902A patent/IL208902A/en active IP Right Grant
-
2013
- 2013-11-14 JP JP2013236328A patent/JP5819909B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2014062106A (ja) | 2014-04-10 |
CN102014939A (zh) | 2011-04-13 |
US20110038949A1 (en) | 2011-02-17 |
JP5819909B2 (ja) | 2015-11-24 |
EP2296681A4 (en) | 2012-04-18 |
KR20100137013A (ko) | 2010-12-29 |
AU2009241221A1 (en) | 2009-11-05 |
EP2296681A2 (en) | 2011-03-23 |
MY161415A (en) | 2017-04-14 |
CH701268B1 (de) | 2012-06-15 |
WO2009133573A3 (en) | 2010-05-06 |
WO2009133573A2 (en) | 2009-11-05 |
MX2010011715A (es) | 2010-12-06 |
CA2722121A1 (en) | 2009-11-05 |
MX339704B (es) | 2016-06-06 |
KR101321031B1 (ko) | 2013-10-23 |
AU2009241221B2 (en) | 2015-02-05 |
BRPI0912026A2 (pt) | 2015-10-06 |
IL208902A0 (en) | 2011-01-31 |
JP2011518876A (ja) | 2011-06-30 |
SG190594A1 (en) | 2013-06-28 |
IL208902A (en) | 2015-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201001592A1 (ru) | Гомеопатическое лекарственное средство | |
NI201100194A (es) | Derivados de tieno [2, 3 - b] piridina como inhibidores de la replicación viral | |
MX2010005631A (es) | Nuevos compuestos de hidrocarburo ciclicos para el tratamiento de enfermedades. | |
AU2008215743B2 (en) | A composition for selective serotonin reuptake inhibition and process thereof | |
RU2010150478A (ru) | Способы профилактики и лечения нейродегенеративных заболеваний | |
RU2006101225A (ru) | Пероральные лекарственные формы мемантина | |
RU2011111792A (ru) | Применение парацетамола и ибупрофена в лечении | |
EA201101622A1 (ru) | Пептидная фармацевтическая композиция, средство на ее основе для лечения гастродуоденальных заболеваний, вызываемых helicobacter pylori, и способ его использования | |
JP2010083758A (ja) | 抗ウイルス剤 | |
CN101167889A (zh) | 一种治疗昏厥、风湿性关节炎的中药 | |
CN101829241B (zh) | 一种治疗带状疱疹、黄水疮或急性湿疹的外搽酊剂 | |
CN108837143B (zh) | 曲普瑞林的应用 | |
CN101897891A (zh) | 一种治疗瘿瘤的中药散剂 | |
CN103749551A (zh) | 一种预防感冒的空气消毒剂 | |
RU2245157C2 (ru) | Биологически активная добавка для профилактики и лечения гриппа "фитогриппин" | |
RU2125456C1 (ru) | Гомеопатическое лекарственное средство "фарингол-arn" | |
CN103157077A (zh) | 姜枣丸 | |
CN101732418A (zh) | 一种治疗糖尿病的中药糊剂 | |
CN101757216A (zh) | 一种治疗牙痛的中药 | |
Antoliková et al. | ST. JOHN’S WORT MEDICINAL PRODUCTS IN SLOVAKIA–EFFICACY OF ORAL FORMULATION OF SJW PRODUCTS. | |
CN102125639A (zh) | 镇痛药 | |
RU2442599C2 (ru) | ГОМЕОПАТИЧЕСКОЕ ЛЕКАРСТВЕННОЕ СРЕДСТВО И БИОЛОГИЧЕСКИ АКТИВНАЯ ДОБАВКА К ПИЩЕ, СОДЕРЖАЩИЕ Nisylen, Сера, Euphrasia, Belladonna И/ИЛИ Mercurius solubilis | |
CN109908215A (zh) | 一种治疗鼻炎的药物组合物及其应用 | |
CN103536875B (zh) | 一种治疗少儿牙龈炎的药剂的制备方法 | |
Sahoo et al. | Drug toxicity (Aushadha vyapata) in ayurveda |